Aarti Pharmalabs Share Price

    NSE
    903.55
    -9.10 (0.99%)
    AARTIPHARM • 02 Jul, 2025 | 01:50 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Aarti Pharmalabs Stock Performance

    1W Return4.30
    1Y Return39.62
    Today's Low902.7
    Prev. Close912.65
    Mkt Cap (Cr.)8,271.77
    1M Return1.52
    3Y Return0.00
    52-Week High949.5
    Open913.90
    PE Ratio32.15
    6M Return30.55
    Today's High928.9
    52-Week Low551.05
    Face Value5

    Aarti Pharmalabs Company background

    Founded in: 2019
    Managing director: Narendra Jagannath Salvi
    Aarti Pharmachem Limited, formerly known as Aarti Organics Limited, was incorporated as a Public Limited Company in 2019. The Company changed the name from Aarti Organics Limited to Aarti Pharmachem Limited on July 1, 2021. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anticancer, AntiAsthma, AntiHypertensive etc.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.The RD centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company has commenced operations for its semicommercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity was enhanced to 5000 TPA in 202324.

    As of 02 Jul, 2025, Aarti Pharmalabs share price is ₹903.8. The stock opened at ₹913.9 and had closed at ₹912.6 the previous day. During today’s trading session, Aarti Pharmalabs share price moved between ₹902.70 and ₹928.90, with an average price for the day of ₹915.80. Over the last 52 weeks, the stock has recorded a low of ₹551.05 and a high of ₹949.50. In terms of performance, Aarti Pharmalabs share price has increased by 29.2% over the past six months and has increased by 40.99% over the last year.

    Read More
    View details of Market Depth

    Aarti Pharmalabs Fundamental

    Market Cap (in crs)

    8,271.77

    Face Value

    5

    Turnover (in lacs)

    1,524.59

    Key Metrics

    Qtr Change %
    Near 52W High of ₹949.50
    19.9
    Dividend yield 1yr %
    Below industry Median
    0.4

    Aarti Pharmalabs Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Aarti Pharmalabs Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    563.78 Cr
    537.78 Cr
    458.03 Cr
    555.49 Cr
    505.77 Cr
    Aarti Pharmalabs Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022
    2125.19 Cr
    1857.5 Cr
    1947.55 Cr
    1202.46 Cr
    Aarti Pharmalabs Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    88.34 Cr
    73.99 Cr
    54.62 Cr
    55.45 Cr
    65.25 Cr
    Aarti Pharmalabs Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022
    272.4 Cr
    216.9 Cr
    193.49 Cr
    122.25 Cr

    Aarti Pharmalabs Result Highlights

    • Aarti Pharmalabs Ltd reported a 6.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 4.5%.

    • Its expenses for the quarter were down by 6.8% QoQ and 3.5% YoY.

    • The net profit decreased 11.8% QoQ and increased 52.2% YoY.

    • The earnings per share (EPS) of Aarti Pharmalabs Ltd stood at 7.2 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Aarti Pharmalabs

    Promoter
    44.3%
    Foreign Institutions
    7.4%
    Mutual Funds
    0.8%
    Domestic Institutions
    7.5%
    Public
    40.8%
    Promoter
    44.7%
    Foreign Institutions
    8.6%
    Mutual Funds
    3.9%
    Domestic Institutions
    10.4%
    Public
    36.3%
    Promoter
    46.1%
    Foreign Institutions
    7.4%
    Mutual Funds
    4.9%
    Domestic Institutions
    11.3%
    Public
    35.2%
    Promoter
    46.5%
    Foreign Institutions
    7.1%
    Mutual Funds
    4.7%
    Domestic Institutions
    11.5%
    Public
    35%
    Promoter
    46.5%
    Foreign Institutions
    8.3%
    Mutual Funds
    2.7%
    Domestic Institutions
    10%
    Public
    35.2%
    Promoter
    46.5%
    Foreign Institutions
    8.2%
    Mutual Funds
    2%
    Domestic Institutions
    9.9%
    Public
    35.4%

    Aarti Pharmalabs Technical Analysis

    Moving Averages Analysis
    903.55
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    886.20
    10Day EMA
    880.10
    12Day EMA
    879.60
    20Day EMA
    876.30
    26Day EMA
    870.90
    50Day EMA
    842.20
    100Day EMA
    792.40
    200Day EMA
    727.30
    5Day SMA
    880.40
    10Day SMA
    870.50
    20Day SMA
    888.00
    30Day SMA
    887.20
    50Day SMA
    835.60
    100Day SMA
    783.00
    150Day SMA
    732.60
    200Day SMA
    707.90
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    307967 Rs
    593954 Rs
    Week Rs
    201206 Rs
    398093 Rs
    Month Rs
    150644 Rs
    319915 Rs
    903.97
    Pivot
    Resistance
    First Resistance
    923.08
    Second Resistance
    933.52
    Third Resistance
    952.63
    Support
    First Support
    893.53
    Second support
    874.42
    Third Support
    863.98
    Relative Strength Index
    59.52
    Money Flow Index
    52.24
    MACD
    8.66
    MACD Signal
    10.72
    Average True Range
    33.97
    Average Directional Index
    27.68
    Rate of Change (21)
    2.52
    Rate of Change (125)
    34.58
    Name
    Holding Percent
    Ntasain Discovery Master Fund
    2.21
    Life Insurance Corporation Of India
    6.06

    Aarti Pharmalabs Latest News

    25 JUN 2025 | Wednesday

    Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window

    18 JUN 2025 | Wednesday

    Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 MAY 2025 | Tuesday

    Aarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    View More

    Aarti Pharmalabs Share Price FAQs

    Aarti Pharmalabs share price is ₹903.55 in NSE and ₹903.4 in BSE as on 2/7/2025.

    Aarti Pharmalabs share price in the past 1-year return was 39.61. The Aarti Pharmalabs share hit a 1-year low of Rs. 551.05 and a 1-year high of Rs. 949.5.

    The market cap of Aarti Pharmalabs is Rs. 8271.77 Cr. as of 2/7/2025.

    The PE ratios of Aarti Pharmalabs is 32.15 as of 2/7/2025.

    The PB ratios of Aarti Pharmalabs is 4.48 as of 2/7/2025

    The Mutual Fund Shareholding in Aarti Pharmalabs was 0.78% at the end of 2/7/2025.

    You can easily buy Aarti Pharmalabs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Aarti Pharmalabs share price is ₹949.5 and ₹551.05 as of 2/7/2025.

    Please be aware that Aarti Pharmalabs stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.42
    -1.78 (-2.65%)
    139.55
    -1.95 (-1.38%)
    688.00
    +4.20 (+0.61%)
    2,626.50
    +4.70 (+0.18%)
    167.50
    -2.89 (-1.70%)
    390.30
    -5.55 (-1.40%)
    164.71
    +4.65 (+2.91%)
    259.20
    -1.80 (-0.69%)
    423.10
    -9.15 (-2.12%)
    404.80
    -1.75 (-0.43%)
    Top Gainers
    164.97
    +4.91 (+3.07%)
    1,056.80
    +27.20 (+2.64%)
    12,464.00
    +254.00 (+2.08%)
    12,570.00
    +128.00 (+1.03%)
    4,258.50
    +32.50 (+0.77%)
    Top Losers
    676.65
    -19.80 (-2.84%)
    2,001.80
    -52.00 (-2.53%)
    857.50
    -21.60 (-2.46%)
    916.00
    -20.65 (-2.20%)
    3,592.10
    -74.60 (-2.03%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -